ATHN Transcends

ATHN Transcends: Natural History Cohort Study of Bleeding Symptoms and Treatment Outcomes in Patients with Glanzmann Thrombasthenia

Author(s):

Divyaswathi Citla Sridhar, Sanjay Ahuja, Tammuella Chrisentery-Singleton, Carrie O’Neill, Catherine Rea, Jigar Amin, Michael Recht, Meera Chitlur
Publication:
World Federation of Hemophilia (WFH) World Congress 2024
Date:
April 21-24, 2024
Topics:
ATHN Transcends, Glanzmann thrombasthenia, GT

ATHN Transcends – Hemophilia Gene Therapy Outcomes Arm: A Long-Term Follow-Up Study on Safety and Effectiveness of Gene Therapy on People with Hemophilia

Author(s):

Janice M. Staber, Blanca Salazar, Roberto Guillen-Gonzalez, Michael Recht, Tammuella Chrisentery-Singleton, Ulrike M. Reiss
Publication:
World Federation of Hemophilia (WFH) World Congress 2024
Date:
April 21-24, 2024
Topics:
ATHN Transcends, gene therapy, hemophilia

A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment in People with Non-Neoplastic Hematologic Disorders

Author(s):

Tammuella Chrisentery-Singleton, Carrie O’Neill, Nana Ama Afari-Dwamena, Andrea Adeusi, Michael Recht
Publication:
World Federation of Hemophilia (WFH) World Congress 2024
Date:
April 21-24, 2024
Topics:
ATHN Transcends, blood disorders

ATHN Transcends: Hemophilia Gene Therapy Outcomes Arm: A Long-Term Follow-Up Study on Safety and Effectiveness of Gene Therapy on People with Hemophilia

Author(s):

Janice Staber, Blanca Salazar, Roberto Guillen-Gonzalez, Michael Recht, Tammuella Chrisentery-Singleton, Ulrike Reiss
Publication:
Thrombosis & Hemostasis Summit of North America (THSNA) 2024
Date:
April 4-6, 2024
Topics:
ATHN Transcends, gene therapy, hemophilia

ATHN Transcends: Natural History Cohort Study of Bleeding Symptoms and Treatment Outcomes in Patients with Glanzmann Thrombasthenia

Author(s):

Divyaswathi Citla-Sridhar, Sanjay Ahuja, Tammuella Chrisentery-Singleton, Carrie O’Neill, Catherine Rae, Jigar Amin, Michael Recht, Meera Chitlur
Publication:
Thrombosis & Hemostasis Summit of North America (THSNA) 2024
Date:
April 4-6, 2024
Topics:
ATHN Transcends, Glanzmann thrombasthenia, GT

Designing the Ryplazim® (PLASMINOGEN, HUMAN-tvmh) Arm of ATHN Transcends: Safety and Effectiveness in People with Plasminogen Deficiency

Author(s):

Lynn Malec, Rebecca Bialas, Amy Shapiro, Carrie O’Neill, Karen Thibaudeau, Elaine Wagner, Erin Weigel, Michael Recht
Publication:
ISTH 2023 Congress (poster)
Date:
June 24-28, 2023
Topics:
Hemophilia, safety

Designing the Efanesoctocog Alfa Module of ATHN Transcends: Safety in Previously Untreated Patients

Author(s):

Lynn Malec, Courtney Thornburg, Shannon Carpenter, Carrie O’Neill, Mike Recht
Publication:
ISTH 2023 Congress (poster)
Date:
June 24-28, 2023
Topics:
Hemophilia, safety

ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness and Practice of Treatment in People with Non-Neoplastic Hematologic Disorders

Author(s):

Lynn M Malec, Nikki Hirsh, Carrie O’Neill, Crystal Watson, Michael Recht
Publication:
Blood
Date:
November 5, 2021
Topics:
Cohort, Intervention, Non-Neoplastic Hematologic Disorders

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.